Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG)

por Steinberg, Gary, Shore, Neal, Karsh, Lawrence, Bailen, James, Woods, Michael, Schreiber, Taylor, Price, Melissa
Publicado 2015

Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatmen...

por Karsh, Lawrence, Shore, Neal, Soloway, Mark, Bhat, Gajanan, Reddy, Guru, Leu, Szu-Yun, Witjes, J. Alfred
Publicado 2018

A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)

por Steinberg, Gary D, Shore, Neal, Karsh, Lawrence, Bailen, James, Woods, Michael, Schoenberg, Mark, Schreiber, Taylor H, Price, Melissa
Publicado 2014

Intramuscular depot formulations of leuprolide acetate suppress testosterone levels below a 20 ng/dL threshold: a retrospective analysis of two Phase III studies

por Spitz, Aaron, Gittelman, Marc, Karsh, Lawrence I, Dragnic, Sanja, Soliman, Ahmed M, Lele, Aditya, Gruca, Damian, Norton, Michael
Publicado 2016

A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients

por Freedland, Stephen J., Nair, Sandhya, Lin, Xiwu, Karsh, Lawrence, Pieczonka, Christopher, Potluri, Ravi, Brookman-May, Sabine D., Mundle, Suneel D., Fleming, Sarah, Agarwal, Neeraj
Publicado 2023

Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research

por Penson, David F, Lin, Daniel W, Karsh, Lawrence, Quinn, David I, Shevrin, Daniel H, Shore, Neal, Symanowski, James T, Brown, Bruce, Forer, David, Wong, Elaine K, Flanders, Scott C
Publicado 2016

Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

por Schultz, Neil M., Shore, Neal D., Chowdhury, Simon, Klotz, Laurence H., Concepcion, Raoul S., Penson, David F., Karsh, Lawrence I., Yang, Hongbo, Brown, Bruce A., Barlev, Arie, Flanders, Scott C.
Publicado 2018

Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

por Schultz, Neil M, Shore, Neal D, Chowdhury, Simon, Klotz, Laurence H, Concepcion, Raoul S, Penson, David F, Karsh, Lawrence I, Yang, Hongbo, Brown, Bruce A, Barlev, Arie, Flanders, Scott C
Publicado 2018

Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial

por Penson, David F., Armstrong, Andrew J., Concepcion, Raoul S., Agarwal, Neeraj, Olsson, Carl A., Karsh, Lawrence I., Dunshee, Curtis J., Duggan, William, Shen, Qi, Sugg, Jennifer, Haas, Gabriel P., Higano, Celestia S.
Publicado 2021

Correction: Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial

por Penson, David F., Armstrong, Andrew J., Concepcion, Raoul S., Agarwal, Neeraj, Olsson, Carl A., Karsh, Lawrence I., Dunshee, Curtis J., Duggan, William, Shen, Qi, Sugg, Jennifer, Haas, Gabriel P., Higano, Celestia S.
Publicado 2021

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

por Antonarakis, Emmanuel S., Subudhi, Sumit K., Pieczonka, Christopher M., Karsh, Lawrence I., Quinn, David I., Hafron, Jason M., Wilfehrt, Helen M., Harmon, Matthew, Sheikh, Nadeem A., Shore, Neal D., Petrylak, Daniel P.
Publicado 2023

Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting

por White, Jay, Shenoy, B. Vittal, Tutrone, Ronald F., Karsh, Lawrence I., Saltzstein, Daniel R., Harmon, William J., Broyles, Dennis L., Roddy, Tamra E., Lofaro, Lori R., Paoli, Carly J., Denham, Dwight, Reynolds, Mark A.
Publicado 2017

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

por Stopeck, Alison T., Fizazi, Karim, Body, Jean-Jacques, Brown, Janet E., Carducci, Michael, Diel, Ingo, Fujiwara, Yasuhiro, Martín, Miguel, Paterson, Alexander, Tonkin, Katia, Shore, Neal, Sieber, Paul, Kueppers, Frank, Karsh, Lawrence, Yardley, Denise, Wang, Huei, Maniar, Tapan, Arellano, Jorge, Braun, Ada
Publicado 2015

Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase...

por Amin, Asim, Dudek, Arkadiusz Z, Logan, Theodore F, Lance, Raymond S, Holzbeierlein, Jeffrey M, Knox, Jennifer J, Master, Viraj A, Pal, Sumanta K, Miller, Wilson H, Karsh, Lawrence I, Tcherepanova, Irina Y, DeBenedette, Mark A, Williams, W Lee, Plessinger, Douglas C, Nicolette, Charles A, Figlin, Robert A
Publicado 2015

Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach

por Lee, Cheryl T., Mohamed, Nihal E., Pisipati, Sailaja, Shah, Qainat N., Agarwal, Piyush K., Downs, Tracy M., Droller, Michael, Gilbert, Scott M., Goltz, Heather H., Hall, Simon J., Hendawi, Mohamed, Hoffman-Censits, Jean, O’Donnell, Michael, Kaag, Matthew, Karsh, Lawrence I., Kassouf, Wassim, Quale, Diane Z., Sagalowsky, Arthur, Steinberg, Gary D., Latini, David M.
Publicado 2020

Longitudinal follow‐up and performance validation of an mRNA‐based urine test (Xpert(®) Bladder Cancer Monitor ) for surveillance in patients with non‐muscle‐invasive bladder cance...

por Cowan, Barrett, Klein, Eric, Jansz, Ken, Westenfelder, Karl, Bradford, Timothy, Peterson, Chad, Scherr, Douglas, Karsh, Lawrence I., Egerdie, Blair, Witjes, Alfred, Trainer, Andrew, Harris, Richard, Goldfarb, Bernard, Flax, Stanley, Kroeger, Robert, Boyd, Buffi, Liao, Joseph, Patel, Sanjay, Bridge, Julia, Reuter, Victor, Quigley, Neil, Brown, Sarah, Zhao, Suling, Satya, Malini, Bates, Michael, Simon, Iris M., Campbell, Scott, Lotan, Yair
Publicado 2021

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO‐IM...

por Gore, John L., du Plessis, Marguerite, Santiago‐Jiménez, María, Yousefi, Kasra, Thompson, Darby J. S., Karsh, Lawrence, Lane, Brian R., Franks, Michael, Chen, David Y. T., Bandyk, Mark, Bianco, Fernando J., Brown, Gordon, Clark, William, Kibel, Adam S., Kim, Hyung L., Lowrance, William, Manoharan, Murugesan, Maroni, Paul, Perrapato, Scott, Sieber, Paul, Trabulsi, Edouard J., Waterhouse, Robert, Davicioni, Elai, Lotan, Yair, Lin, Daniel W.
Publicado 2017

Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label...

por Chevli, K. Kent, Shore, Neal D., Trainer, Andrew, Smith, Angela B., Saltzstein, Daniel, Ehrlich, Yaron, Raman, Jay D., Friedman, Boris, D’Anna, Richard, Morris, David, Hu, Brian, Tyson, Mark, Sankin, Alexander, Kates, Max, Linehan, Jennifer, Scherr, Douglas, Kester, Steven, Verni, Michael, Chamie, Karim, Karsh, Lawrence, Cinman, Arnold, Meads, Andrew, Lahiri, Soumi, Malinowski, Madlen, Gabai, Nimrod, Raju, Sunil, Schoenberg, Mark, Seltzer, Elyse, Huang, William C.
Publicado 2022